Eileen Banaga, MD
Eileen Banaga, MD
Investigator
AREVA Med
4800 Hampden Lane, Suite 200
Bethesda,
MD
USA
20814
Papers:
157
Long term safety follow up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab